We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TxCell Obtains Manufacturing Accreditation Status

News   Dec 04, 2013

 
TxCell Obtains Manufacturing Accreditation Status
 
 
 

RELATED ARTICLES

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

Emerging Strategies for Treating Opioid-use Disorder

News

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE